158 related articles for article (PubMed ID: 30890498)
1. [Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study].
Yong C; Dan L; Chenhong L; Yan S; Jianfei C; Jianlong G
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):127-133. PubMed ID: 30890498
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Behçet's disease and systemic lupus erythematosus.
Mehana NA; Ghaiad HR; Hassan M; Elsabagh YA; Labib S; Abd-Elmawla MA
Life Sci; 2022 Nov; 309():120965. PubMed ID: 36155183
[TBL] [Abstract][Full Text] [Related]
3. The role of cytokines and T-bet, GATA3, ROR-γt, and FOXP3 transcription factors of T cell subsets in the natural clinical progression of Type 1 Diabetes.
Ozgur BA; Cinar SA; Coskunpinar E; Yilmaz A; Altunkanat D; Deniz G; Gurol AO; Yilmaz MT
Immunol Res; 2023 Jun; 71(3):451-462. PubMed ID: 36595206
[TBL] [Abstract][Full Text] [Related]
4. [Role of Imbalance between Th17 Cells and Treg Cells in the Pathogenesis of Children with Henoch-Schonlein Purpura].
Wang Q; Shi YY; Cao M; Dong W; Zhang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1391-6. PubMed ID: 26524044
[TBL] [Abstract][Full Text] [Related]
5. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis.
Albayrak O; Oray M; Can F; Uludag Kirimli G; Gul A; Tugal-Tutkun I; Onal S
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):52-63. PubMed ID: 30601931
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
[TBL] [Abstract][Full Text] [Related]
7. The Treg/Th17 imbalance in Toxoplasma gondii-infected pregnant mice.
Zhang H; Hu X; Liu X; Zhang R; Fu Q; Xu X
Am J Reprod Immunol; 2012 Feb; 67(2):112-21. PubMed ID: 21923716
[TBL] [Abstract][Full Text] [Related]
8. NF-κB-driven miR-34a impairs Treg/Th17 balance via targeting Foxp3.
Xie M; Wang J; Gong W; Xu H; Pan X; Chen Y; Ru S; Wang H; Chen X; Zhao Y; Li J; Yin Q; Xia S; Zhou X; Liu X; Shao Q
J Autoimmun; 2019 Aug; 102():96-113. PubMed ID: 31130368
[TBL] [Abstract][Full Text] [Related]
9. [Effect of electroacupuncture on Treg/Th17 balance in spleen and serum inflammatory factors in obese mice].
Liu Y; Shu Q; Li JX; Zhou MF; Liu N
Zhen Ci Yan Jiu; 2023 Mar; 48(3):240-6. PubMed ID: 36951075
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
11. MiR-200a expression in CD4+ T cells correlates with the expression of Th17/Treg cells and relevant cytokines in psoriasis vulgaris: A case control study.
Wang XY; Chen XY; Li J; Zhang HY; Liu J; Sun LD
Biomed Pharmacother; 2017 Sep; 93():1158-1164. PubMed ID: 28738533
[TBL] [Abstract][Full Text] [Related]
12. CD4(+) CD25(+) regulatory T cells ameliorate Behcet's disease-like symptoms in a mouse model.
Shim J; Lee ES; Park S; Bang D; Sohn S
Cytotherapy; 2011 Aug; 13(7):835-47. PubMed ID: 21506890
[TBL] [Abstract][Full Text] [Related]
13. Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17.
Lightman S; Taylor SR; Bunce C; Longhurst H; Lynn W; Moots R; Stanford M; Tomkins-Netzer O; Yang D; Calder VL; Haskard DO
Ann Rheum Dis; 2015 Jun; 74(6):1138-44. PubMed ID: 25269831
[TBL] [Abstract][Full Text] [Related]
14. Low-dose IL-2 effectively restored decreased regulatory T cells in patients with Behçet's disease.
Liu X; Li W; Liu X; Luo J; Gao C; Li X
Clin Exp Rheumatol; 2021; 39(4):746-752. PubMed ID: 32662405
[TBL] [Abstract][Full Text] [Related]
15. [Effects of interleukin-35 on the balance of helper T cell 17/regulatory T cell in peripheral blood of patients with oral lichen planus].
Hu WY; Huang YY; Liu T; Cai Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Feb; 55(2):80-85. PubMed ID: 32074667
[No Abstract] [Full Text] [Related]
16. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
[TBL] [Abstract][Full Text] [Related]
17. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
18. Correlation analysis of Treg/Th17 cells and related cytokines in patients with psoriasis vulgaris.
Qu T; Mei C; Zeng Y; Li L; Duan X
J Tradit Chin Med; 2019 Oct; 39(5):700-706. PubMed ID: 32186120
[TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+ regulatory T cells in patients with Behçet's disease.
Hamzaoui K; Hamzaoui A; Houman H
Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S71-8. PubMed ID: 17067431
[TBL] [Abstract][Full Text] [Related]
20. RORC and Foxp3 axis in cerebrospinal fluid of patients with neuro-Behçet's disease.
Hamzaoui K; Borhani Haghighi A; Ghorbel IB; Houman H
J Neuroimmunol; 2011 Apr; 233(1-2):249-53. PubMed ID: 21367463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
